Skip to main content
SpringerLink
Log in

Smoking Cessation

  • Chapter
  • First Online:
COPD

Part of the book series: Respiratory Medicine ((RM))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gratziou C, Tonnesen P (2006) Smoking cessation and prevention. Eur Respir Mon 38:242–57

    Article  Google Scholar 

  2. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23(6):932–46

    Article  CAS  PubMed  Google Scholar 

  3. GIfCOLDG (2005) Workshop Report: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Update 2005: Available at: www.goldcopd.com

  4. Rennard SI, Togo S, Holz O (2006) Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc 3(8):703–8

    Article  CAS  PubMed  Google Scholar 

  5. Repine JE, Bast A, Lankhorst I (1997) Oxidative stress in chronic obstructive pulmonary disease. Oxidative stress study group. Am J Respir Crit Care Med 156(2 Pt 1):341–57

    CAS  PubMed  Google Scholar 

  6. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report (2000) The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. J Am Med Assoc 283(24):3244–54

    Article  Google Scholar 

  7. Karnath B (2002) Smoking cessation. Am J Med 112(5):399–405

    Article  PubMed  Google Scholar 

  8. Fagerstrom K (2002) The epidemiology of smoking: health consequences and benefits of cessation. Drugs 62(Suppl 2):1–9

    Article  PubMed  Google Scholar 

  9. Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observations on male British doctors. Br Med J 2(6051):1525–36

    Article  CAS  PubMed  Google Scholar 

  10. Fiore MC, McCarthy DE, Jackson TC et al (2004) Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med 38(4):412–20

    Article  PubMed  Google Scholar 

  11. Fiore MC, Bailey WC, Cohen SJ (2000) Treating tobacco use and dependence: clinical practice guideline. US Department of Health and Human Services, Public Health Service, Rockville, June 2000

    Google Scholar 

  12. Talwar A, Jain M, Vijayan VK (2004) Pharmacotherapy of tobacco dependence. Med Clin North Am 88(6):1517–34

    Article  CAS  PubMed  Google Scholar 

  13. Chronic obstructive pulmonary disease (2004) National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59(Suppl 1):1–232

    Google Scholar 

  14. Tougaard L, Krone T, Sorknaes A, Ellegaard H (1992) Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. The PASTMA group. Lancet 339(8808):1517–20

    Article  CAS  PubMed  Google Scholar 

  15. Stauffer HP, Riedwyl H (1977) Interaction and pH dependence of effects of nicotine and carbon monoxide in cigarette smoke inhalation experiments with rats. Agents Actions 7(5–6):579–88

    Article  CAS  PubMed  Google Scholar 

  16. Zhou FM, Liang Y, Dani JA (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4(12):1224–9

    Article  CAS  PubMed  Google Scholar 

  17. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382(6588):255–7

    Article  CAS  PubMed  Google Scholar 

  18. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86(9):1119–27

    Article  CAS  PubMed  Google Scholar 

  19. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM (2004) Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs 9(1):39–53

    Article  CAS  PubMed  Google Scholar 

  20. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2001) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (3):CD000146

    Google Scholar 

  21. Shiffman S, Shadel WG, Niaura R et al (2003) Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl) 166(4):343–50

    CAS  Google Scholar 

  22. Hughes JR, Goldstein MG, Hurt RD, Shiffman S (1999) Recent advances in the pharmacotherapy of smoking. J Am Med Assoc 281(1):72–6

    Article  CAS  Google Scholar 

  23. Foulds J, Russell MA, Jarvis MJ, Feyerabend C (1998) Nicotine absorption and dependence in unlicensed lozenges available over the counter. Addiction 93(9):1427–31

    Article  CAS  PubMed  Google Scholar 

  24. West R, Hajek P, Nilsson F, Foulds J, May S, Meadows A (2001) Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology (Berl) 153(2):225–30

    Article  CAS  Google Scholar 

  25. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A (1999) Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 159(17):2033–8

    Article  CAS  PubMed  Google Scholar 

  26. Hughes JR, Shiffman S, Callas P, Zhang J (2003) A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 12(1):21–7

    Article  CAS  PubMed  Google Scholar 

  27. Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K (1996) Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 91(9):1293–306

    CAS  PubMed  Google Scholar 

  28. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR (2002) Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 162(11):1267–76

    Article  CAS  PubMed  Google Scholar 

  29. Murray RP, Bailey WC, Daniels K et al (1996) Safety of nicotine polacrilex gum used by 3, 094 participants in the lung health study. Lung Health Study Research Group. Chest 109(2):438–45

    Article  CAS  PubMed  Google Scholar 

  30. Hoffmann D, Djordjevic MV (1997) Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 11(3):322–9

    Article  CAS  PubMed  Google Scholar 

  31. Benowitz NL, Gourlay SG (1997) Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29(7):1422–31

    Article  CAS  PubMed  Google Scholar 

  32. Keeley EC, Pirwitz MJ, Landau C et al (1996) Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions. Am J Med 101(4):357–63

    Article  CAS  PubMed  Google Scholar 

  33. Nicotine replacement therapy for patients with coronary artery disease (1994) Working group for the study of transdermal nicotine in patients with coronary artery disease. Arch Intern Med 154(9):989–95

    Article  Google Scholar 

  34. Benowitz NL (1993) Nicotine replacement therapy. What has been accomplished – can we do better? Drugs 45(2):157–70

    Article  CAS  PubMed  Google Scholar 

  35. Dempsey D, Jacob P 3rd, Benowitz NL (2002) Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301(2):594–8

    Article  CAS  PubMed  Google Scholar 

  36. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ (2000) Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96(6):967–71

    Article  CAS  PubMed  Google Scholar 

  37. Molyneux A (2004) Nicotine replacement therapy. Br Med J 328(7437):454–6

    Article  Google Scholar 

  38. Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE (2001) Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 15(6):453–67

    Article  CAS  PubMed  Google Scholar 

  39. Fagerstrom KO, Schneider NG, Lunell E (1993) Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology (Berl) 111(3):271–7

    Article  CAS  Google Scholar 

  40. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G (1995) Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24(1):41–7

    Article  CAS  PubMed  Google Scholar 

  41. Bohadana A, Nilsson F, Rasmussen T, Martinet Y (2000) Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 160(20):3128–34

    Article  CAS  PubMed  Google Scholar 

  42. Kassel JD, Stroud LR, Paronis CA (2003) Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 129(2):270–304

    Article  PubMed  Google Scholar 

  43. Ascher JA, Cole JO, Colin JN et al (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56(9):395–401

    CAS  PubMed  Google Scholar 

  44. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295(1):321–7

    CAS  PubMed  Google Scholar 

  45. Rauhut AS, Neugebauer N, Dwoskin LP, Bardo MT (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl) 169(1):1–9

    Article  CAS  Google Scholar 

  46. Hurt RD, Sachs DP, Glover ED et al (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337(17):1195–202

    Article  CAS  PubMed  Google Scholar 

  47. Hays JT, Hurt RD, Rigotti NA et al (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med 135(6):423–33

    CAS  PubMed  Google Scholar 

  48. Hays JT, Ebbert JO (2003) Bupropion sustained release for treatment of tobacco dependence. Mayo Clin Proc 78(8):1020–4, quiz 4

    Article  CAS  PubMed  Google Scholar 

  49. Hughes JR, Stead LF, Lancaster T (2003) Antidepressants for smoking cessation. Cochrane Database Syst Rev (2):CD000031

    Google Scholar 

  50. Coleman T (2001) Smoking cessation: integrating recent advances into clinical practice. Thorax 56(7):579–82

    Article  CAS  PubMed  Google Scholar 

  51. Martinez-Raga J, Keaney F, Sutherland G, Perez-Galvez B, Strang J (2003) Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile. Addict Biol 8(1):13–21

    Article  CAS  PubMed  Google Scholar 

  52. Tashkin D, Kanner R, Bailey W et al (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 357(9268):1571–5

    Article  CAS  PubMed  Google Scholar 

  53. Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP (2005) Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 165(19):2286–92

    Article  CAS  PubMed  Google Scholar 

  54. Jorenby DE, Leischow SJ, Nides MA et al (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340(9):685–91

    Article  CAS  PubMed  Google Scholar 

  55. Gonzales D, Rennard SI, Nides M et al (2006) Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. J Am Med Assoc 296(1):47–55

    Article  CAS  Google Scholar 

  56. Jorenby DE, Hays JT, Rigotti NA et al (2006) Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. J Am Med Assoc 296(1):56–63

    Article  CAS  Google Scholar 

  57. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR (2006) Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. J Am Med Assoc 296(1):64–71

    Article  CAS  Google Scholar 

  58. Tonnesen P, Carrozzi L, Fagerstrom KO et al (2007) Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 29(2):390–417

    Article  CAS  PubMed  Google Scholar 

  59. George TP, Vessicchio JC, Termine A, Jatlow PI, Kosten TR, O’Malley SS (2003) A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biol Psychiatry 53(2):136–43

    Article  CAS  PubMed  Google Scholar 

  60. Edwards NB, Murphy JK, Downs AD, Ackerman BJ, Rosenthal TL (1989) Doxepin as an adjunct to smoking cessation: a double-blind pilot study. Am J Psychiatry 146(3):373–6

    CAS  PubMed  Google Scholar 

  61. Gourlay SG, Stead LF, Benowitz NL (2000) Clonidine for smoking cessation. Cochrane Database Syst Rev (2):CD000058

    Google Scholar 

  62. Gourlay SG, Benowitz NL (1995) Is clonidine an effective smoking cessation therapy? Drugs 50(2):197–207

    Article  CAS  PubMed  Google Scholar 

  63. Anthenelli RM (2004) Effects of rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS-US trial (Smoking cessation in smokers motivated to quit). In: American college of cardiology 53rd annual scientific meeting, New Orleans, 9 March 2004

    Google Scholar 

  64. Laviolette SR, van der Kooy D (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 5(1):55–65

    Article  CAS  PubMed  Google Scholar 

  65. Park CR, Munday DL (2002) Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 237(1–2):215–26

    Article  CAS  PubMed  Google Scholar 

  66. Westman EC, Tomlin KF, Perkins CE, Rose JE (2001) Oral nicotine solution for smoking cessation: a pilot tolerability study. Nicotine Tob Res 3(4):391–6

    Article  CAS  PubMed  Google Scholar 

  67. Lindmayer K, Horwith G, Fattom A, et.al (2003) Results of phase I double-blinded controlled safety and immunogenicity trial of NICVAX, a nicotine conjugated vaccine. Society for Research on Nicotine and Tobacco, 9th Annual Meeting, New Orleans (Abstract)

    Google Scholar 

  68. Cachill K, Stead LF, Lancaster T (2007) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (January 24) (1):CD006103

    Google Scholar 

  69. Rigotti NA (2002) Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346(7):506–12

    Article  PubMed  Google Scholar 

  70. Villano LM, White AR (2004) Alternative therapies for tobacco dependence. Med Clin North Am 88(6):1607–21

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Pulmonary and Critical Care Medicine, North Shore University Hospital, Manhasset, NY, USA

    Arunabh Talwar

  2. Department of Medicine, NYU School of Medicine, Great Neck, NY, USA

    Virginia Reichert

  3. Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA

    Kalpalatha Guntupalli

Authors
  1. Arunabh Talwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia Reichert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kalpalatha Guntupalli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Section of Pulmonary and Critical Care M, Baylor College of Medicine, 1504 Taub Loop, Houston, 77030, Texas, USA

    Nicola A. Hanania

  2. Michael E. DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd., Houston, 77030, Texas, USA

    Amir Sharafkhaneh

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Talwar, A., Reichert, V., Guntupalli, K. (2011). Smoking Cessation. In: Hanania, N., Sharafkhaneh, A. (eds) COPD. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-357-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-357-8_9

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-949-9

  • Online ISBN: 978-1-59745-357-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation